Weight-loss jab gets green light to be used to prevent heart attacks in UK

Wegovy wins approvals from MHRA as drug to help reduce risk of heart problems in people who are overweight

Health officials in the UK have given the green light for a weight-loss jab to be used to prevent heart attacks and strokes in overweight people.

Semaglutide, sold under the brand name Wegovy, has already been approved for weight management in people with obesity.